Low-level laser therapy improves pain in postcesarean section: a randomized clinical trial.
Alane Macatrao Pires de Holanda Araujo, Kassio Rafael Rocha de Sena, Edson Meneses da Silva Filho...
https://pubmed.ncbi.nlm.nih.gov/31659541/Actively Recruiting
Led by Universidad Nacional Autonoma de Honduras · Updated on 2026-10-07
210
Participants Needed
1
Research Sites
4 weeks
Total Duration
Postoperative pain after cesarean section is a common challenge that can slow recovery, delay walking, and affect newborn care. This trial evaluates the safety and effectiveness of photobiomodulation PBM, a non-invasive light therapy using red and near-infrared light, as an additional treatment to standard pain relief methods in postpartum women undergoing cesarean delivery. The study is randomized, double-blind, and sham-controlled, involving 210 women aged 18 to 40 years. Participants are randomly assigned to one of two groups. One group receives active PBM using the MitoQUAD4 Belt device applied over the surgical wound through a sterile dressing for three 15-minute sessions at 30 minutes, 24 hours, and between 36 to 48 hours after surgery, alongside standard multimodal analgesia. The other group receives a sham device that looks and operates like the active device but delivers no therapeutic light, applied on the same schedule with the same standard pain treatments. During the 48 hours following surgery, participants will be monitored for pain intensity at rest and with movement, use of rescue pain medications, wound healing using the REEDA scale, time to first independent walking, maternal satisfaction with childbirth experience, and any adverse events. The main outcome is pain intensity at rest 24 hours after surgery. Safety and treatment effects will be assessed through questionnaires, clinical evaluations, and adverse event tracking over this period.
CONDITIONS
Efficacy and Safety of Photobiomodulation for Postoperative Pain After Cesarean Section
R
Ricardo A. Gutierrez-Ramirez, MD, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universidad Nacional Autonoma de Honduras
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 48 hours post-surgery
Participants receive either active photobiomodulation therapy or a sham device applied over the surgical wound in three 15-minute sessions at 30 minutes, 24 hours, and 36-48 hours after cesarean delivery, alongside standard pain management.
3 treatment sessions
Duration - 48 hours post-surgery
Participants are monitored for pain, wound healing, use of rescue pain medication, time to walking, maternal satisfaction, and any adverse events up to 48 hours after surgery.
Assessments during and after treatment sessions
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alane Macatrao Pires de Holanda Araujo, Kassio Rafael Rocha de Sena, Edson Meneses da Silva Filho...
https://pubmed.ncbi.nlm.nih.gov/31659541/Universidad Nacional Autonoma de Honduras
Lead Sponsor